Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Day One Biopharmaceuticals (DAWN) Accumulated Depreciation & Amortization (2022 - 2023)

Day One Biopharmaceuticals (DAWN) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $30000.0 as the latest value for Q3 2023.

  • For Q3 2023, Accumulated Depreciation & Amortization fell 63.86% year-over-year to $30000.0; the TTM value through Sep 2023 reached $30000.0, down 63.86%, while the annual FY2022 figure was $6000.0, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization was $30000.0 for Q3 2023 at Day One Biopharmaceuticals, up from $18000.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $83000.0 in Q3 2022, with the low at $6000.0 in Q4 2022.